Living leukocyte‐based drug delivery systems

Y Chen, D Qin, J Zou, X Li, XD Guo, Y Tang… - Advanced …, 2023 - Wiley Online Library
Leukocytes play a vital role in immune responses, including defending against invasive
pathogens, reconstructing impaired tissue, and maintaining immune homeostasis. When the …

Trial watch: chemotherapy-induced immunogenic cell death in oncology

J Sprooten, RS Laureano, I Vanmeerbeek… - …, 2023 - Taylor & Francis
Immunogenic cell death (ICD) refers to an immunologically distinct process of regulated cell
death that activates, rather than suppresses, innate and adaptive immune responses. Such …

The future of affordable cancer immunotherapy

N Schaft, J Dörrie, G Schuler… - Frontiers in …, 2023 - frontiersin.org
The treatment of cancer was revolutionized within the last two decades by utilizing the
mechanism of the immune system against malignant tissue in so-called cancer …

Dendritic cells as orchestrators of anticancer immunity and immunotherapy

I Heras-Murillo, I Adán-Barrientos, M Galán… - Nature Reviews …, 2024 - nature.com
Dendritic cells (DCs) are a heterogeneous group of antigen-presenting innate immune cells
that regulate adaptive immunity, including against cancer. Therefore, understanding the …

[HTML][HTML] Integrating immunopeptidome analysis for the design and development of cancer vaccines

S Feola, J Chiaro, V Cerullo - Seminars in immunology, 2023 - Elsevier
The repertoire of naturally presented peptides within the MHC (major histocompatibility
complex) or HLA (human leukocyte antigens) system on the cellular surface of every …

The cell stress and immunity cycle in cancer: toward next generation of cancer immunotherapy

RS Laureano, I Vanmeerbeek, J Sprooten… - Immunological …, 2024 - Wiley Online Library
The cellular stress and immunity cycle is a cornerstone of organismal homeostasis. Stress
activates intracellular and intercellular communications within a tissue or organ to initiate …

Recent advances in biomimetic strategies for the immunotherapy of glioblastoma

H You, S Geng, S Li, M Imani, D Brambilla, T Sun… - Biomaterials, 2024 - Elsevier
Immunotherapy is regarded as one of the most promising approaches for treating tumors,
with a multitude of immunotherapeutic thoughts currently under consideration for the lethal …

The interface of tumour-associated macrophages with dying cancer cells in immuno-oncology

I Vanmeerbeek, J Govaerts, RS Laureano, J Sprooten… - Cells, 2022 - mdpi.com
Tumour-associated macrophages (TAMs) are essential players in the tumour
microenvironment (TME) and modulate various pro-tumorigenic functions such as …

Breakthroughs in cancer immunotherapy: an overview of T cell, NK cell, Mφ, and DC-based treatments

S Lee, TD Kim - International Journal of Molecular Sciences, 2023 - mdpi.com
Efforts to treat cancer using chimeric antigen receptor (CAR)-T therapy have made
astonishing progress and clinical trials against hematopoietic malignancies have …

Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells

J Sprooten, I Vanmeerbeek, A Datsi, J Govaerts… - Cell Reports …, 2024 - cell.com
Current immunotherapies provide limited benefits against T cell-depleted tumors, calling for
therapeutic innovation. Using multi-omics integration of cancer patient data, we predict a …